How big is Codexis, Inc.?

As of Jun 18, Codexis, Inc. has a market capitalization of 183.92 million, with net sales of 49.81 million and a net profit of -74.46 million over the latest four quarters. The company reported shareholder's funds of 66.93 million and total assets of 149.01 million as of Dec 24.

Market Cap: As of Jun 18, Codexis, Inc. has a market capitalization of 183.92 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Codexis, Inc. reported net sales of 49.81 million and a net profit of -74.46 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 66.93 million and total assets of 149.01 million.

What does Codexis, Inc. do?

Codexis, Inc. is a protein engineering company that develops biocatalysts for pharmaceuticals and fine chemicals, classified as a micro-cap with a market cap of approximately $183.92 million. As of March 2025, it reported net sales of $8 million and a net loss of $21 million.

Overview:<BR>Codexis, Inc. is a protein engineering company engaged in the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals, operating within the specialty chemicals industry and classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 8 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -21 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 183.92 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.57 <BR>Return on Equity: -143.65% <BR>Price to Book: 3.71<BR><BR>Contact Details:<BR>Address: 200 Penobscot Dr, REDWOOD CITY CA: 94063-4718 <BR>Tel: 1 650 4218100 <BR>Website: https://www.codexis.com/

Should I buy, sell or hold Codexis, Inc.?

Who are in the management team of Codexis, Inc.?

As of March 2022, the management team of Codexis, Inc. includes Mr. Bernard Kelley (Independent Chairman), Mr. John Nicols (CEO), and several independent directors: Dr. Jennifer Aaker, Mr. Thomas Baruch, Ms. Pam Cheng, Mr. Byron Dorgan, and Mr. David Smith. They are responsible for the company's strategic direction and governance.

As of March 2022, the management team of Codexis, Inc. includes the following individuals:<BR><BR>- Mr. Bernard Kelley, Independent Chairman of the Board<BR>- Mr. John Nicols, President, Chief Executive Officer, and Director<BR>- Dr. Jennifer Aaker, Independent Director<BR>- Mr. Thomas Baruch, Independent Director<BR>- Ms. Pam Cheng, Independent Director<BR>- Mr. Byron Dorgan, Independent Director<BR>- Mr. David Smith, Independent Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and governance.

Is Codexis, Inc. technically bullish or bearish?

As of August 25, 2025, Codexis, Inc. shows a mildly bearish trend with mixed signals from MACD and Bollinger Bands, underperforming the S&P 500 significantly year-to-date and over five years.

As of 25 August 2025, the technical trend for Codexis, Inc. has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD shows a mildly bullish stance, indicating mixed signals. The daily moving averages are bearish, and the Bollinger Bands reflect a mildly bearish trend on the weekly and bearish on the monthly. The KST is bullish weekly but bearish monthly, and Dow Theory indicates a mildly bullish stance on both weekly and monthly time frames. <BR><BR>In terms of performance, Codexis has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -47.80% compared to the S&P 500's 12.22%, and a 5-year return of -79.56% versus the S&P 500's 96.61%. Overall, the current technical stance is mildly bearish, driven primarily by the bearish daily moving averages and the mixed signals from MACD and Bollinger Bands.